These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 3202041

  • 1. Immunomodulation of murine leishmaniasis with cyclosporin A.
    Behforouz NC, Wenger CD.
    Adv Exp Med Biol; 1988; 239():379-84. PubMed ID: 3202041
    [No Abstract] [Full Text] [Related]

  • 2. Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.
    Bogdan C, Streck H, Röllinghoff M, Solbach W.
    Clin Exp Immunol; 1989 Jan; 75(1):141-6. PubMed ID: 2702771
    [Abstract] [Full Text] [Related]

  • 3. Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone.
    Mahmoudvand H, Tavakoli R, Sharififar F, Minaie K, Ezatpour B, Jahanbakhsh S, Sharifi I.
    Pharm Biol; 2015 Jul; 53(7):1052-7. PubMed ID: 25471014
    [Abstract] [Full Text] [Related]

  • 4. Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Röllinghoff M.
    Infect Immun; 1986 Dec; 54(3):909-12. PubMed ID: 3491051
    [Abstract] [Full Text] [Related]

  • 5. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M.
    J Immunol; 1986 Jul 15; 137(2):702-7. PubMed ID: 3487578
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis vulgaris and Nigella sativa against Leishmania tropica.
    Mahmoudvand H, Sharififar F, Rahmat MS, Tavakoli R, Dezaki ES, Jahanbakhsh S, Sharifi I.
    J Vector Borne Dis; 2014 Dec 15; 51(4):294-9. PubMed ID: 25540961
    [Abstract] [Full Text] [Related]

  • 7. Immunomodulation by chemotherapeutic agents against Leishmaniasis.
    Saha P, Mukhopadhyay D, Chatterjee M.
    Int Immunopharmacol; 2011 Nov 15; 11(11):1668-79. PubMed ID: 21875692
    [Abstract] [Full Text] [Related]

  • 8. Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.
    Heidari-Kharaji M, Taheri T, Doroud D, Habibzadeh S, Rafati S.
    Appl Microbiol Biotechnol; 2016 Aug 15; 100(16):7051-60. PubMed ID: 26960322
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic treatment of BALB/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major.
    Behforouz NC, Wenger CD, Mathison BA.
    J Immunol; 1986 Apr 15; 136(8):3067-75. PubMed ID: 3958489
    [Abstract] [Full Text] [Related]

  • 10. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES, Allahverdiyev AM, Bagirova M, Rafailovich M.
    Acta Trop; 2017 May 15; 169():30-42. PubMed ID: 28111133
    [Abstract] [Full Text] [Related]

  • 11. A preliminary observation on in vitro inhibitory effect of cyclosporin-A upon growth of Leishmania tropica promastigotes.
    Eldaw A, Sequeira RP, Eldirdiri AB.
    J Egypt Soc Parasitol; 1989 Jun 15; 19(1):301-5. PubMed ID: 2708862
    [Abstract] [Full Text] [Related]

  • 12. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
    Rosypal AC, Werbovetz KA, Salem M, Stephens CE, Kumar A, Boykin DW, Hall JE, Tidwell RR.
    J Parasitol; 2008 Jun 15; 94(3):743-9. PubMed ID: 18605790
    [Abstract] [Full Text] [Related]

  • 13. PEGylated silver doped zinc oxide nanoparticles as novel photosensitizers for photodynamic therapy against Leishmania.
    Nadhman A, Nazir S, Khan MI, Arooj S, Bakhtiar M, Shahnaz G, Yasinzai M.
    Free Radic Biol Med; 2014 Dec 15; 77():230-8. PubMed ID: 25266330
    [Abstract] [Full Text] [Related]

  • 14. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 15. Targets for immunochemotherapy in leishmaniasis.
    Mukhopadhyay D, Saha P, Chatterjee M.
    Expert Rev Anti Infect Ther; 2012 Mar 15; 10(3):261-4. PubMed ID: 22397558
    [No Abstract] [Full Text] [Related]

  • 16. Sinefungin as treatment for American Leishmania in sensitive BALB/c and resistant C57BL/6 mice.
    Avila JL, Rojas T, Monzón H, Convit J.
    Am J Trop Med Hyg; 1990 Aug 15; 43(2):139-45. PubMed ID: 2389821
    [Abstract] [Full Text] [Related]

  • 17. The mechanism behind the antileishmanial effect of zinc sulphate. I. An in-vitro study.
    Al-Mulla Hummadi YM, Najim RA, Al-Bashir NM.
    Ann Trop Med Parasitol; 2005 Jan 15; 99(1):27-36. PubMed ID: 15701252
    [Abstract] [Full Text] [Related]

  • 18. Potantial utility of disulfiram against leishmaniasis.
    Namazi MR.
    Indian J Med Res; 2008 Feb 15; 127(2):193-4. PubMed ID: 18403799
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes.
    Mosser DM, Handman E.
    J Leukoc Biol; 1992 Oct 15; 52(4):369-76. PubMed ID: 1402387
    [Abstract] [Full Text] [Related]

  • 20. Antileishmanial effects of clofazimine and other antimycobacterial agents.
    Evans AT, Croft SL, Peters W, Neal RA.
    Ann Trop Med Parasitol; 1989 Oct 15; 83(5):447-54. PubMed ID: 2619361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.